- Home
- PTCT vs PFSI Comparison
PTCT vs PFSI Comparison
Compare PTCT & PFSI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | PTCT | PFSI |
|---|---|---|
| Founded | 1998 | 2008 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Finance: Consumer Services |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 6.1B | 4.8B |
| IPO Year | 2013 | 2013 |
Fundamental Metrics
Financial Performance| Metric | PTCT | PFSI |
|---|---|---|
| Price | $69.35 | $92.35 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 18 | 8 |
| Target Price | $76.28 | ★ $139.13 |
| AVG Volume (30 Days) | 1.1M | ★ 1.3M |
| Earning Date | 02-19-2026 | 01-29-2026 |
| Dividend Yield | N/A | ★ 1.30% |
| EPS Growth | N/A | ★ 59.25 |
| EPS | 8.94 | ★ 9.30 |
| Revenue | $1,779,150,000.00 | ★ $3,459,816,000.00 |
| Revenue This Year | $132.16 | N/A |
| Revenue Next Year | N/A | $14.75 |
| P/E Ratio | ★ $7.77 | $9.89 |
| Revenue Growth | ★ 97.54 | 70.77 |
| 52 Week Low | $35.95 | $85.74 |
| 52 Week High | $87.50 | $160.36 |
Technical Indicators
Market Signals| Indicator | PTCT | PFSI |
|---|---|---|
| Relative Strength Index (RSI) | 37.18 | 24.66 |
| Support Level | $69.75 | $88.39 |
| Resistance Level | $76.99 | $97.51 |
| Average True Range (ATR) | 2.60 | 5.51 |
| MACD | -0.44 | -3.02 |
| Stochastic Oscillator | 13.85 | 5.58 |
Price Performance
Historical ComparisonAbout PTCT PTC Therapeutics Inc.
PTC Therapeutics Inc is a biopharmaceutical company that discovers, develops and commercializes clinically differentiated medicines that provide benefits to children and adults living with rare disorders. Its diversified therapeutic portfolio that includes several commercial products and product candidates in various stages of development, including discovery, research and clinical stages, focused on the development of new treatments for multiple therapeutic areas for rare diseases relating to neurology and metabolism. The Company views its operations and manages its business in one operating segment: life science.
About PFSI PennyMac Financial Services Inc.
PennyMac Financial Services Inc is a specialty financial services firm with a comprehensive mortgage platform and integrated business focused on the production and servicing of U.S. residential mortgage loans. The company operates through two segments: production and servicing. The production segment performs loan origination, acquisition and sale activities. The servicing segment performs loan servicing for newly originated loans.